Immunogenicity and safety of Tetraxim versus local DTP + IPV.
Phase of Trial: Phase III
Latest Information Update: 13 Mar 2013
At a glance
- Drugs DTaP poliovirus vaccine; DTaP vaccine; Poliovirus vaccine
- Indications Diphtheria; Pertussis; Poliomyelitis; Tetanus
- Focus Pharmacodynamics; Registrational
- Sponsors Sanofi
- 16 Feb 2010 Actual number of patients added to 442 as reported by ClinicalTrials.gov.
- 16 Feb 2010 Actual end date added [1 Jul 2008] as reported by ClinicalTrials.gov.
- 16 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History